The positive is that NPAT guidance is unchanged and 2H21 is expected to deliver ~2.5 times 1H21 NPAT
The negative it calling professional services from ongoing client demand is 'attached recurring revenue'......it declined over the last two 6 month reporting periods so is that really that reliable to term recurring.....I'm sure there is a better way to express this, because it looks like an own goal to class this as 'recurring revenue' when it has declined for a SaaS company.
The other point of concern is that R&D capitalised increased significantly in 1H21......R&D in itself is not bad, but was this capitalised to make the 1H21 results look better than reported.....perhaps legit, and perhaps they redeployed project staff into R&D but interesting to see how this looks in 2H21.
Anyway, FY 2021 NPAT of 32-35m means EPS of 13-14c and a PE of 21-23 on FY2021 earnings...nNot necessarily expensive, but perhaps appropriate given the growth reflected in the last 9 months.
2H21 project fees will highlight a turnaround I think
- Forums
- ASX - By Stock
- BVS
- Ann: Investor Presentation
Ann: Investor Presentation, page-2
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BVS (ASX) to my watchlist
|
|||||
Last
$1.34 |
Change
0.040(3.08%) |
Mkt cap ! $600.7M |
Open | High | Low | Value | Volume |
$1.30 | $1.35 | $1.29 | $1.156M | 869.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6379 | $1.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.35 | 7824 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 6379 | 1.330 |
1 | 8352 | 1.320 |
1 | 8352 | 1.315 |
1 | 1750 | 1.310 |
1 | 5000 | 1.305 |
Price($) | Vol. | No. |
---|---|---|
1.345 | 7824 | 1 |
1.350 | 49426 | 8 |
1.360 | 1900 | 1 |
1.370 | 2500 | 1 |
1.380 | 5000 | 2 |
Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
Featured News
BVS (ASX) Chart |